Author: claimsbot

1. An operation unit-equipped device comprising an operation unit including
a property controller configured to store, in a storage unit, operation property information of an application for controlling a main body of the operation unit-equipped device or changed information that is a changed piece of the operation property information; and
a control unit configured to
control, when the changed information is stored in the storage unit, an operation of the main body by an operation of the application corresponding to the changed information, and
control, when the changed information is not stored in the storage unit, an operation of the main body by an operation of the application corresponding to the operation property information.
2. The operation unit-equipped device according to claim 1, wherein
the operation unit further includes a screen display controller configured to store, in the storage unit, initial screen layout information indicating a predetermined initial screen layout or defined screen layout information indicating a defined screen layout,
the control unit displays, when the defined screen layout information is stored in the storage unit, a display screen indicated by the defined screen layout information on a display unit, and
the control unit displays, when the defined screen layout information is not stored in the storage unit, a display screen indicated by the initial screen layout information on the display unit.
3. The operation unit-equipped device according to claim 2, wherein
the screen display controller stores a screen component and the operation property information which are associated through the application in the storage unit, and
the control unit displays a display screen corresponding to the associated screen component and operation property information on the display unit.
4. The operation unit-equipped device according to claim 1, wherein
the operation unit further includes a post-processing controller configured to store post-processing information indicating a post-processing defined in the main body in the storage unit, and
the control unit controls the main body to perform the post-processing indicated by the post-processing information stored in the storage unit after an operation of the main body by the application is completed.
5. The operation unit-equipped device according to claim 1, wherein
the main body includes a Web application interface, and
the control unit communicates with the main body via the Web application interface to control the main body.
6. The operation unit-equipped device according to claim 1, wherein a combination of pieces of operation property information with high usage frequency is set for the operation property information as predetermined information or initial information.
7. A computer program product for being executed on a computer comprising:
a property controller configured to store, in a storage unit, operation property information of an application for controlling a main body or changed information that is a changed piece of the operation property information; and
a control unit configured to
control, when the changed information is stored in the storage unit, an operation of the main body by an operation of the application corresponding to the changed information, and
control, when the changed information is not stored in the storage unit, an operation of the main body by an operation of the application corresponding to the operation property information.
8. The computer program product according to claim 7, wherein
the computer further comprises a screen display controller configured to store, in the storage unit, initial screen layout information indicating a predetermined initial screen layout or defined screen layout information indicating a defined screen layout,
the control unit displays, when the defined screen layout information is stored in the storage unit, a display screen indicated by the defined screen layout information on a display unit, and
the control unit displays, when the defined screen layout information is not stored in the storage unit, a display screen indicated by the initial screen layout information on the display unit.
9. The computer program product according to claim 8, wherein
the screen display controller stores a screen component and the operation property information which are associated through the application in the storage unit, and
the control unit displays a display screen corresponding to the associated screen component and operation property information on the display unit.
10. The computer program product according to claim 7, wherein
the computer further comprises a post-processing controller configured to store post-processing information indicating a post-processing defined in the main body in the storage unit, and
the control unit controls the main body to perform the post-processing indicated by the post-processing information stored in the storage unit after an operation of the main body by the application is completed.
11. The computer program product according to claim 7, wherein
the main body includes a Web application interface, and
the control unit communicates with the main body via the Web application interface to control the main body.
12. The computer program product according to claim 7, wherein a combination of pieces of operation property information with high usage frequency is set for the operation property information as predetermined information or initial information.
13. An information processing method comprising:
storing, by a property controller, in a storage unit, operation property information of an application for controlling a main body or changed information that is a changed piece of the operation property information;
controlling, by a control unit, when the changed information is stored in the storage unit, an operation of the main body by an operation of the application corresponding to the changed information; and
controlling, by the control unit, when the changed information is not stored in the storage unit, an operation of the main body by an operation of the application corresponding to the operation property information.
14. The information processing method according to claim 13, further comprising:
storing, by a screen display controller, in the storage unit, initial screen layout information indicating a predetermined initial screen layout or defined screen layout information indicating a defined screen layout;
displaying, by the control unit, when the defined screen layout information is stored in the storage unit, a display screen indicated by the defined screen layout information on a display unit; and
displaying, by the control unit, when the defined screen layout information is not stored in the storage unit, a display screen indicated by the initial screen layout information on the display unit.
15. The information processing method according to claim 14, further comprising:
storing, by the screen display controller, a screen component and the operation property information which are associated through the application in the storage unit; and
displaying, by the control unit, a display screen corresponding to the associated screen component and operation property information on the display unit.
16. The information processing method according to claim 13, further comprising:
storing, by a post-processing controller, post-processing information indicating a post-processing defined in the main body in the storage unit; and
controlling, by the control unit, the main body to perform the post-processing indicated by the post-processing information stored in the storage unit after an operation of the main body by the application is completed.
17. The information processing method according to claim 13, wherein
the main body includes a Web application interface, and
the control unit communicates with the main body via the Web application interface to control the main body.
18. The information processing method according to claim 13, wherein a combination of pieces of operation property information with high usage frequency is set for the operation property information as predetermined information or initial information.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A circuit comprising:
a logging transistor receiving an input current at an input terminal;
a guard circuit coupled between the input terminal and a base of the logging transistor and arranged to force the input current into the input terminal of the logging transistor; and
a positioning circuit coupled between the base and an output terminal of the logging transistor and arranged to maintain a voltage of the logging transistor.
2. The circuit of claim 1 where:
the guard circuit comprises a first feedback loop; and
the positioning circuit comprises a second feedback loop.
3. The circuit of claim 1 where the guard circuit comprises a buffer amplifier.
4. The circuit of claim 3 where:
the input terminal of the logging transistor comprises a collector; and
the buffer amplifier includes an input coupled to the collector and an output coupled to the base of the logging transistor.
5. The circuit of claim 1 where the positioning circuit comprises an operational amplifier.
6. The circuit of claim 5 where the operational amplifier includes a first input coupled to the base of the logging transistor, a second input coupled to a reference signal, and an output coupled to the output terminal of the logging transistor.
7. The circuit of claim 1 further comprising a second logging transistor coupled to the first logging transistor and arranged to provide log-ratio operation.
8. The circuit of claim 7 further comprising a second guard circuit arranged to force a second input current into an input terminal of the second logging transistor.
9. The circuit of claim 8 where the guard circuit comprises a second buffer amplifier.
10. The circuit of claim 8 where:
the output terminal of the first logging transistor includes an emitter coupled to an emitter of the second logging transistor; and
the first and second logging transistors are arranged to provide a \u0394VBE output between the bases of the first and second logging transistors.

1. An integrated circuit to control a process performed at a mobile station, the process comprising:
receiving information related to a set of sequences configured to be available in a cell for use by the mobile station, the information being broadcasted from a base station;
selecting a sequence from the set of sequences available in the cell; and
random-access-preamble-transmitting the selected sequence;
wherein the set of sequences available in the cell includes a sequence of r=a and a sequence of r=N\u2212a, where r is a sequence number, a is an integer, and N is a sequence length, and the allocated sequences are defined by the following equation or an equation cyclic shifted from the following equation:
c
r

\u2061

(
k
)
=

exp
\u2062

{
–
j

\u2062
2
\u2062
\u2062
\u03c0
\u2062
\u2062
r

N

\u2062

(
k
\u2061

(

k
+
1

)
2

+
qk

)
}
where k=0, 1, 2, . . . N\u22121, and q is an integer, and
the sequence of r=a and the sequence of r=N\u2212a are conjugate to each other.
2. The integrated circuit according to claim 1, comprising:
circuitry which, in operation, controls the process;
at least one input coupled to the circuitry, wherein the at least one input, in operation, inputs the information related to the set of sequences available in the cell; and
at least one output coupled to the circuitry, wherein the at least one output, in operation, outputs the selected sequence to be transmitted.
3. The integrated circuit according to claim 2, wherein the set of sequences available in the cell further includes a sequence of r=a\u2032 (a\u2032\u2260a) and a sequence of r=N\u2212a\u2032.
4. The integrated circuit according to claim 2, wherein the N is a prime number.
5. The integrated circuit according to claim 2, wherein the selecting includes randomly selecting the sequence from the set of sequences available in the cell.
6. The integrated circuit according to claim 2, wherein the set of sequences available in the cell is configured by a network that controls the base station.
7. The integrated circuit according to claim 2, wherein a number of the sequences configured to be included in the set of sequences available in the cell is less than the N.
8. The integrated circuit according to claim 2, wherein the information broadcasted from the base station includes an index indicative of the set of sequences available in the cell.
9. The integrated circuit according to claim 2, wherein the at least one output and the at least one input, in operation, are coupled to an antenna.
10. An integrated circuit comprising circuitry, which, in operation:
controls reception of information related to a set of sequences configured to be available in a cell for use by a mobile station, the information being broadcasted from a base station;
controls selection of a sequence from the set of sequences available in the cell; and
controls random-access-preamble-transmission of the selected sequence;
wherein the set of sequences available in the cell includes a sequence of r=a and a sequence of r=N\u2212a, where r is a sequence number, a is an integer, and N is a sequence length, and the allocated sequences are defined by the following equation or an equation cyclic shifted from the following equation:
c
r

\u2061

(
k
)
=

exp
\u2062

{
–
j

\u2062
2
\u2062
\u2062
\u03c0
\u2062
\u2062
r

N

\u2062

(
k
\u2061

(

k
+
1

)
2

+
qk

)
}
where k=0, 1, 2, . . . N\u22121, and q is an integer, and
the sequence of r=a and the sequence of r=N\u2212a are conjugate to each other.
11. The integrated circuit according to claim 10, further comprising:
at least one input coupled to the circuitry, wherein the at least one input, in operation, inputs the information related to the set of sequences available in the cell; and
at least one output coupled to the circuitry, wherein the at least one output, in operation, outputs the selected sequence to be transmitted.
12. The integrated circuit according to claim 11, wherein the set of sequences available in the cell further includes a sequence of r=a\u2032 (a\u2032\u2260a) and a sequence of r=N\u2212a\u2032.
13. The integrated circuit according to claim 11, wherein the N is a prime number.
14. The integrated circuit according to claim 11, wherein the selection includes randomly selecting the sequence from the set of sequences available in the cell.
15. The integrated circuit according to claim 11, wherein the set of sequences available in the cell is configured by a network that controls the base station.
16. The integrated circuit according to claim 11, wherein a number of the sequences configured to be included in the set of sequences available in the cell is less than the N.
17. The integrated circuit according to claim 11, wherein the information broadcasted from the base station includes an index indicative of the set of sequences available in the cell.
18. The integrated circuit according to claim 11, wherein the at least one output and the at least one input, in operation, are coupled to an antenna.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A compound of formula I
wherein:
R1 is CO2R5 or CONR6R7;
R2 is cycloalkoxy or bridged 2.1.1, 2.2.1, 2.2.2, 3.1.1, or 3.2.1 bicycloalkoxy where the cycloalkyl or bridged bicycloalkyl moiety is substituted with 0-3 alkyl substituents;
or R2 is N(R8)(R9);
or R2 is pyrrolidinyl, piperidinyl, piperazinyl, N-alkylpiperazinyl, N-(BOC)piperazinyl, N-benzylmethylpiperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 1 substituent selected from alkenyl, R11, (R11)alkyl, (R11CO)alkyl, pyrazinyl, pyrimidinyl, and phenyl where phenyl is substituted with 0-2 halo, alkyl, haloalkyl, cyano, hydroxy, alkoxy, haloalkoxy, CONH2, CONH(alkyl), or CON(alkyl)2 substituents;
or R2 is homopiperazinyl or diazepanone, and is substituted with 0-2 substituents selected from the group consisting of halo, hydroxy, alkyl, hydroxyalkyl, alkoxyalkyl, amino, alkylamino, dialkylamino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, pyrrolidinyl, piperidinyl, piperazinyl, N-(alkyl)piperazinyl, morpholinyl, thiomorpholinyl, pyridinyl, pyrazinyl, pyrimidinyl, pyrimidinyloxy, phenyl substituted with 0-2 halo, alkyl, or alkoxy substituents, benzyl, (pyridinyl)methyl, benzyloxycarbonyl, alkylcarbonyl, alkoxycarbonyl, (R11)alkyl, and (R11CO)alkyl;
or R2 is
R3 is hydrogen, halo, alkyl, alkenyl, hydroxy, benzyloxy, or alkoxy;
R4 is C5-7cycloalkyl;
R5 is hydrogen or alkyl;
R6 is hydrogen, alkyl, cycloalkyl, alkoxy, or SO2R10;
R7 is hydrogen, alkyl, or cycloalkyl;
or NR6R7 taken together is pyrrolidinyl, piperidinyl, piperazinyl, N-(alkyl)piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl;
R8 is 4-piperidinyl, 4-(N-alkyl)piperidinyl, 3-(N-alkyl)pyrrolidinyl, (R11)alkyl, (R11CO)alkyl, (amino)cycloalkyl, (alkylamino)cycloalkyl, or (dialkylamino)cycloalkyl;
R9 is hydrogen, alkyl, cycloalkyl, hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, or dialkylaminoalkyl;
R10 is alkyl, haloalkyl, cycloalkyl, phenyl, amino, alkylamino, dialkylamino, benzylamino, or (benzyl)(alkyl)amino;
or R10 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 0-2 substituents selected from halo and alkyl; and
R11 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 0-2 substituents selected from halo and alkyl;
or a pharmaceutically acceptable salt thereof.
2. A compound of claim 1 where
R1 is CO2R5 or CONR6R7;
R2 is cycloalkoxy or bridged 2.1.1, 2.2.1, 2.2.2, 3.1.1, or 3.2.1 bicycloalkoxy, where the cycloalkyl or bridged bicycloalkyl moiety is substituted with 0-3 alkyl substituents;
or R2 is N(R8)(R9);
or R2 is pyrrolidinyl, piperidinyl, piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 1 substituent selected from R11, (R11)alkyl, (R11CO)alkyl, pyrazinyl, pyrimidinyl, pyrimidinyloxy, and phenyl where phenyl is substituted with 0-2 halo, alkyl or alkoxy substituents;
or R2 is homopiperazinyl or diazepanone, and is substituted with 0-2 substituents selected from the group consisting of halo, hydroxy, alkyl, hydroxyalkyl, alkoxyalkyl, amino, alkylamino, dialkylamino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, pyrrolidinyl, piperidinyl, piperazinyl, N-(alkyl)piperazinyl, morpholinyl, thiomorpholinyl, pyridinyl, pyrazinyl, pyrimidinyl, pyrimidinyloxy, phenyl substituted with 0-2 halo, alkyl, or alkoxy substituents, benzyl, (pyridinyl)methyl, benzyloxycarbonyl, alkylcarbonyl, alkoxycarbonyl, (R11)alkyl, and (R11CO)alkyl;
or R2 is
R3 is hydrogen, halo, alkyl, alkenyl, hydroxy, benzyloxy, or alkoxy;
R4 is C5-7cycloalkyl;
R5 is hydrogen or alkyl;
R6 is hydrogen, alkyl, cycloalkyl, alkoxy, or SO2R10;
R7 is hydrogen, alkyl, or cycloalkyl;
or NR6R7 taken together is pyrrolidinyl, piperidinyl, piperazinyl, N-(alkyl)piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl;
R8 is 4-piperidinyl, 4-(N-alkyl)piperidinyl, (R11)alkyl, (R11CO)alkyl, (amino)cycloalkyl, (alkylamino)cycloalkyl, or (dialkylamino)cycloalkyl;
R9 is hydrogen, alkyl, cycloalkyl, hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, or dialkylaminoalkyl;
R10 is alkyl, haloalkyl, cycloalkyl, phenyl, amino, alkylamino, dialkylamino, benzylamino, or (benzyl)(alkyl)amino;
or R10 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 0-2 substituents selected from halo and alkyl; and
R11 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 0-2 substituents selected from halo and alkyl;
or a pharmaceutically acceptable salt thereof.
3. A compound of claim 1 where R is carboxy.
4. A compound of claim 1 where R1 is CONR6R7, R6 is SO2R10, and R7 is hydrogen.
5. A compound of claim 1 where R2 is NR8R9.
6. A compound of claim 1 where R2 is pyrrolidinyl, piperidinyl, piperazinyl, N-alkylpiperazinyl, N-(BOC)piperazinyl, N-benzylmethylpiperazinyl, homomorpholinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl, and is substituted with 1 substituent selected from alkenyl, R11, (R11)alkyl, (R11CO)alkyl, pyrazinyl, pyrimidinyl, and phenyl where phenyl is substituted with 0-2 halo, alkyl or alkoxy substituents.
7. A compound of claim 1 where R3 is hydrogen.
8. A compound of claim 1 where R3 is halo, alkyl, or alkoxy.
9. A compound of claim 1 where R4 is cyclohexyl.
10. A compound selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
11. A compound of claim 1 selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
12. A composition comprising a compound of claim 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
13. The composition of claim 12 further comprising at least one additional compound having therapeutic benefits for HCV wherein the compound is selected from the group consisting of interferons, cyclosporins, interleukins, HCV metalloprotease inhibitors, HCV serine protease inhibitors, HCV polymerase inhibitors, HCV helicase inhibitors, HCV NS4B protein inhibitors, HCV entry inhibitors, HCV assembly inhibitors, HCV egress inhibitors, HCV NS5A protein inhibitors, HCV NS5B protein inhibitors, and HCV replicon inhibitors.
14. A method of treating hepatitis C infection comprising administering a therapeutically effective amount of a compound of claim 1 to a patient.
15. The method of claim 14 further comprising administering at least one additional compound having therapeutic benefits for HCV wherein the compound is selected from the group consisting of interferons, cyclosporins, interleukins, HCV metalloprotease inhibitors, HCV serine protease inhibitors, HCV polymerase inhibitors, HCV helicase inhibitors, HCV NS4B protein inhibitors, HCV entry inhibitors, HCV assembly inhibitors, HCV egress inhibitors, HCV NS5A protein inhibitors, HCV NS5B protein inhibitors, and HCV replicon inhibitors.